What is non-oncology precision medicine?

Non-oncology precision medicine involves tailoring medical treatment to the individual characteristics of each patient, considering factors such as genetics, lifestyle, and environment. Unlike traditional approaches, precision medicine aims to provide more effective and personalized therapies across various medical conditions beyond cancer.

How big is the Non-Oncology Precision Medicine Market?

The global Non-Oncology Precision Medicine Market size was estimated at USD 76.8 Billion in 2023 and is expected to reach USD 192.1 Billion in 2033.

What is the Non-Oncology Precision Medicine Market growth?

The global Non-Oncology Precision Medicine Market is expected to grow at a compound annual growth rate of 9.6%. From 2024 To 2033

Who are the key companies/players in the Non-Oncology Precision Medicine Market?

Some of the key players in the Non-Oncology Precision Medicine Markets are Pfizer Inc., Abbott Laboratories, Medtronic, Novartis, Eli Lilly & Company, Laboratory Corporation of America Holdings, Qiagen, Inc., Quest Diagnostics Inc., Bristol Myers Squibb, Danaher Corporation.

What are the key drivers propelling the growth of the non-oncology precision medicine market?

The growth of the non-oncology precision medicine market can be attributed to several factors, including advancements in genomic technologies, increased understanding of disease mechanisms, rising demand for personalized healthcare, and the expanding application of data analytics in healthcare decision-making.

Which therapeutic areas are targeted by non-oncology precision medicine?

Non-oncology precision medicine encompasses a wide range of therapeutic areas, including but not limited to cardiovascular diseases, neurological disorders, rare genetic conditions, autoimmune disorders, and infectious diseases. The approach is versatile and can potentially benefit patients across various medical specialties.

What role does data analytics play in non-oncology precision medicine?

Data analytics plays a crucial role in non-oncology precision medicine by enabling the interpretation of large-scale biological and clinical data. Through sophisticated algorithms and machine learning techniques, data analytics can identify patterns, biomarkers, and therapeutic targets, facilitating the development of tailored treatment approaches for individual patients.

How does non-oncology precision medicine impact healthcare outcomes and costs?

Non-oncology precision medicine has the potential to improve healthcare outcomes by optimizing treatment efficacy, reducing adverse effects, and enhancing patient satisfaction. By targeting therapies based on individual characteristics, precision medicine may also contribute to cost savings by minimizing trial-and-error approaches, avoiding unnecessary treatments, and reducing hospitalizations.

Global Non-Oncology Precision Medicine Market-By Products (Diagnostics, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory, Infectious Diseases, Neurology, Others), By End-User (Hospitals, Diagnostics Center, Research & Academic Institutes, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: March 2024
Report ID: 117276
Number of Pages: 237
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Non-Oncology Precision Medicines Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Non-Oncology Precision Medicines Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Non-Oncology Precision Medicines Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-Economic Factors/Geopolitical Factors
- 3. Global Non-Oncology Precision Medicines Market Analysis and Forecast, By Segment, 2024-2033
  - 3.1. Key Findings
  - 3.2. Global Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 3.3. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
    3.3.1. Diagnostics
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Therapeutics
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
  - 3.4. Global Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 3.5. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
    3.5.1. CNS
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Oncology
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Immunology
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
    3.5.4. Respiratory diseases
    3.5.4.1. Insights
    3.5.4.2. Key Takeaways
    3.5.5. Infectious Diseases
    3.5.5.1. Insights
    3.5.5.2. Key Takeaways
    3.5.6. Neurology
    3.5.6.1. Insights
    3.5.6.2. Key Takeaways
    3.5.7. Others
    3.5.7.1. Insights
    3.5.7.2. Key Takeaways
- 3.6. Global Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
- 3.7. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 3.7.1. Diagnostic Centres
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Hospitals
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Research & Academic Institutes
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
    3.7.4. Others
    3.7.4.1. Insights
    3.7.4.2. Key Takeaways
- 4. Global Non-Oncology Precision Medicines Market Analysis and Forecast, By Region, 2024-2033
  - 4.1. Key Findings
  - 4.2. Global Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2024-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
- 4.3. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By Region
- 5. North America Non-Oncology Precision Medicines Market Analysis and Forecast, 2024-2033
  - 5.1. Key Findings
  - 5.2. North America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 5.3. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
  - 5.4. North America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 5.5. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
  - 5.6. North America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 5.7. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 5.8. North America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 5.9. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
    5.9.1. The US
    5.9.2. Canada
- 6. Europe Non-Oncology Precision Medicines Market Analysis and Forecast, 2024-2033
  - 6.1. Key Findings
  - 6.2. Europe Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 6.3. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
  - 6.4. Europe Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 6.5. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
  - 6.6. Europe Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 6.7. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 6.8. Europe Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 6.9. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
    6.9.1. Germany
    6.9.2. The UK
    6.9.3. France
    6.9.4. Spain
    6.9.5. Italy
    6.9.6. Russia
    6.9.7. Netherlands
    6.9.8. Rest of Europe
- 7. Asia Pacific Non-Oncology Precision Medicines Market Analysis and Forecast, 2024-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 7.3. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
  - 7.4. Asia Pacific Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 7.5. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 7.7. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 7.8. Asia Pacific Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 7.9. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
    7.9.1. China
    7.9.2. Japan
    7.9.3. South Korea
    7.9.4. India
    7.9.5. New Zealand
    7.9.6. Singapore
    7.9.7. Thailand
    7.9.8. Vietnam
    7.9.9. Rest of Asia Pacific
- 8. Latin America Non-Oncology Precision Medicines Market Analysis and Forecast, 2024-2033
  - 8.1. Key Findings
  - 8.2. Latin America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 8.3. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
  - 8.4. Latin America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 8.5. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
  - 8.6. Latin America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 8.7. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 8.8. Latin America Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 8.9. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
    8.9.1. Brazil
    8.9.2. Mexico
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Non-Oncology Precision Medicines Market Analysis and Forecast, 2024-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2024-2033
  - 9.3. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
  - 9.4. Middle East & Africa Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2024-2033
  - 9.5. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2024-2033
  - 9.7. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
  - 9.8. Middle East & Africa Non-Oncology Precision Medicines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2024-2033
  - 9.9. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
    9.9.1. South Africa
    9.9.2. Saudi Arabia
    9.9.3. UAE
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Pfizer
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Abbott Laboratories
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Medtronic
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Novartis
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Eli lilly & Company
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. Laboratory Corporation of America Holdings
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Qiagen, Inc.
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Quest Diagnostics, Inc.
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Bristol Myers Squibb
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Danaher Corporation
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 2. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 3. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 4. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By Region, 2024-2033
- Table 5. North America Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 6. North America Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 7. North America Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 8. North America Non-Oncology Precision Medicines Market Value (US$ Mn), By Country, 2024-2033
- Table 9. The US Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 10. The US Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 11. The US Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 12. Canada Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 13. Canada Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 14. Canada Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 15. Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 16. Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 17. Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 18. Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By Country, 2024-2033
- Table 19. Germany Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 20. Germany Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 21. Germany Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 22. The UK Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 23. The UK Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 24. The UK Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 25. France Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 26. France Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 27. France Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 28. Spain Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 29. Spain Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 30. Spain Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 31. Italy Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 32. Italy Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 33. Italy Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 34. Russia Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 35. Russia Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 36. Russia Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 37. Netherlands Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 38. Netherlands Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 39. Netherlands Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 40. Rest of Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 41. Rest of Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 42. Rest of Europe Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 43. Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 44. Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 45. Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 46. Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By Country, 2024-2033
- Table 47. China Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 48. China Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 49. China Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 50. India Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 51. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 52. Global Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 53. Japan Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 54. Japan Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 55. Japan Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 56. South Korea Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 57. South Korea Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 58. South Korea Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 59. New Zealand Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 60. New Zealand Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 61. New Zealand Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 62. Singapore Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 63. Singapore Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 64. Singapore Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 65. Thailand Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 66. Thailand Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 67. Thailand Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 68. Vietnam Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 69. Vietnam Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 70. Vietnam Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 71. Rest of Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 72. Rest of Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 73. Rest of Asia Pacific Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 74. Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 75. Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 76. Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 77. Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By Country, 2024-2033
- Table 78. Brazil Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 79. Brazil Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 80. Brazil Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 81. Mexico Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 82. Mexico Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 83. Mexico Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 84. Rest of Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 85. Rest of Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 86. Rest of Latin America Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 87. Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 88. Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 89. Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 90. Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Country, 2024-2033
- Table 91. South Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 92. South Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 93. South Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 94. Saudi Arabia Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 95. Saudi Arabia Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 96. Saudi Arabia Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 97. UAE Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 98. UAE Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 99. UAE Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
- Table 100. Rest of Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Product, 2024-2033
- Table 101. Rest of Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By Application, 2024-2033
- Table 102. Rest of Middle East & Africa Non-Oncology Precision Medicines Market Value (US$ Mn), By End-User, 2024-2033
List of Figures
- Figure 1. Global Non-Oncology Precision Medicines Market Snapshot: Market Value (US$ Mn), 2024-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Non-Oncology Precision Medicines Market
- Figure 5. Global Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 6. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 7. Global Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 8. Global Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 9. North America Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 10. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 11. North America Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostics, 2024-2033
- Figure 12. North America Non-Oncology Precision Medicines Market (US$ Mn), by Therapeutics, 2024-2033
- Figure 13. North America Non-Oncology Precision Medicines Market Analysis, By Technology, 2018, 2023 and 2033
- Figure 14. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Technology
- Figure 15. North America Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 16. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 17. North America Non-Oncology Precision Medicines Market (US$ Mn), by CNS, 2024-2033
- Figure 18. North America Non-Oncology Precision Medicines Market (US$ Mn), by Oncology, 2024-2033
- Figure 19. North America Non-Oncology Precision Medicines Market (US$ Mn), by Immunology, 2024-2033
- Figure 20. North America Non-Oncology Precision Medicines Market (US$ Mn), by Respiratory diseases, 2024-2033
- Figure 21. North America Non-Oncology Precision Medicines Market (US$ Mn), by Infectious Diseases, 2024-2033
- Figure 22. North America Non-Oncology Precision Medicines Market (US$ Mn), by Neurology, 2024-2033
- Figure 23. North America Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 24. North America Non-Oncology Precision Medicines Market Analysis, By End-User, 2018, 2023 and 2033
- Figure 25. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
- Figure 26. North America Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostic Centres, 2024-2033
- Figure 27. North America Non-Oncology Precision Medicines Market (US$ Mn), by Hospitals, 2024-2033
- Figure 28. North America Non-Oncology Precision Medicines Market (US$ Mn), by Research & Academic Institutes, 2024-2033
- Figure 29. North America Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 30. North America Non-Oncology Precision Medicines Market Analysis, By Country, 2018, 2023 and 2033
- Figure 31. North America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
- Figure 32. Europe Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 33. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 34. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostics, 2024-2033
- Figure 35. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Therapeutics, 2024-2033
- Figure 36. Europe Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 37. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 38. Europe Non-Oncology Precision Medicines Market (US$ Mn), by CNS, 2024-2033
- Figure 39. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Oncology, 2024-2033
- Figure 40. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Immunology, 2024-2033
- Figure 41. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Respiratory diseases, 2024-2033
- Figure 42. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Infectious Diseases, 2024-2033
- Figure 43. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Neurology, 2024-2033
- Figure 44. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 45. Europe Non-Oncology Precision Medicines Market Analysis, By End-User, 2018, 2023 and 2033
- Figure 46. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
- Figure 47. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostic Centres, 2024-2033
- Figure 48. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Hospitals, 2024-2033
- Figure 49. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Research & Academic Institutes, 2024-2033
- Figure 50. Europe Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 51. Europe Non-Oncology Precision Medicines Market Analysis, By Country, 2018, 2023 and 2033
- Figure 52. Europe Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
- Figure 53. Asia Pacific Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 54. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 55. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostics, 2024-2033
- Figure 56. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Therapeutics, 2024-2033
- Figure 57. Asia Pacific Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 58. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 59. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by CNS, 2024-2033
- Figure 60. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Oncology, 2024-2033
- Figure 61. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Immunology, 2024-2033
- Figure 62. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Respiratory diseases, 2024-2033
- Figure 63. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Infectious Diseases, 2024-2033
- Figure 64. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Neurology, 2024-2033
- Figure 65. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 66. Asia Pacific Non-Oncology Precision Medicines Market Analysis, By End-User, 2018, 2023 and 2033
- Figure 67. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
- Figure 68. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostic Centres, 2024-2033
- Figure 69. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Hospitals, 2024-2033
- Figure 70. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Research & Academic Institutes, 2024-2033
- Figure 71. Asia Pacific Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 72. Asia Pacific Non-Oncology Precision Medicines Market Analysis, By Country, 2018, 2023 and 2033
- Figure 73. Asia Pacific Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
- Figure 74. Latin America Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 75. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 76. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostics, 2024-2033
- Figure 77. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Therapeutics, 2024-2033
- Figure 78. Latin America Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 79. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 80. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by CNS, 2024-2033
- Figure 81. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Oncology, 2024-2033
- Figure 82. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Immunology, 2024-2033
- Figure 83. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Respiratory diseases, 2024-2033
- Figure 84. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Infectious Diseases, 2024-2033
- Figure 85. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Neurology, 2024-2033
- Figure 86. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 87. Latin America Non-Oncology Precision Medicines Market Analysis, By End-User, 2018, 2023 and 2033
- Figure 88. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
- Figure 89. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostic Centres, 2024-2033
- Figure 90. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Hospitals, 2024-2033
- Figure 91. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Research & Academic Institutes, 2024-2033
- Figure 92. Latin America Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 93. Latin America Non-Oncology Precision Medicines Market Analysis, By Country, 2018, 2023 and 2033
- Figure 94. Latin America Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
- Figure 95. Middle East & Africa Non-Oncology Precision Medicines Market Analysis, By Product, 2018, 2023 and 2033
- Figure 96. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Product
- Figure 97. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostics, 2024-2033
- Figure 98. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Therapeutics, 2024-2033
- Figure 99. Middle East & Africa Non-Oncology Precision Medicines Market Analysis, By Application, 2018, 2023 and 2033
- Figure 100. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Application
- Figure 101. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by CNS, 2024-2033
- Figure 102. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Oncology, 2024-2033
- Figure 103. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Immunology, 2024-2033
- Figure 104. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Respiratory diseases, 2024-2033
- Figure 105. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Infectious Diseases, 2024-2033
- Figure 106. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Neurology, 2024-2033
- Figure 107. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 108. Middle East & Africa Non-Oncology Precision Medicines Market Analysis, By End-User, 2018, 2023 and 2033
- Figure 109. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By End-User
- Figure 110. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Diagnostic Centres, 2024-2033
- Figure 111. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Hospitals, 2024-2033
- Figure 112. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Research & Academic Institutes, 2024-2033
- Figure 113. Middle East & Africa Non-Oncology Precision Medicines Market (US$ Mn), by Others, 2024-2033
- Figure 114. Middle East & Africa Non-Oncology Precision Medicines Market Analysis, By Country, 2018, 2023 and 2033
- Figure 115. Middle East & Africa Non-Oncology Precision Medicines Market Attractiveness Analysis, By Country
- Pfizer Inc Company Profile
- Abbott Laboratories
- Medtronic
- Novartis AG Company Profile
- Eli Lilly & Company
- Laboratory Corporation of America Holdings
- Qiagen, Inc.
- Quest Diagnostics Inc.
- Bristol Myers Squibb Company Profile
- Danaher Corporation Company Profile
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients